Skip directly to site content Skip directly to search


Español  Other Languages


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
 Search
		×
			Vaccines site
			Vaccines site
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


National Immunization Surveys (NIS)


Section Navigation
			
			CDC Home








About the National Immunization Surveys (NIS)						Print
																Related Pages
										On This Page
			NORCCurrent SurveysNIS-ChildNIS-TeenNIS-CIMNIS-CCMNIS-ACM
The National Immunization Surveys (NIS) are a group of phone surveys used to monitor vaccination coverage among children 19–35 months and teens 13–17 years, flu vaccinations for children 6 months–17 years, and COVID-19 vaccination for children and teens in eligible age groups and for adults 18 years and older. The surveys are sponsored and conducted by the National Center for Immunization and Respiratory Diseases (NCIRD) of the Centers for Disease Control and Prevention (CDC) and authorized by the Public Health Service Act [Sections 306]. Data collection for the first survey began in April 1994 to check vaccination coverage after measles outbreaks in the early 1990s.
The NIS provides current, population-based, state and local area estimates of vaccination coverage among children and teens using a standard survey methodology. The surveys collect data through telephone interviews with parents or guardians in all 50 states, the District of Columbia, and some U.S. territories. Cell phone numbers are randomly selected and called to enroll one or more age-eligible child or teen from the household. The parents and guardians of eligible children are asked during the interview for the names of their children’s vaccination providers and permission to contact them. With this permission, a questionnaire is mailed to each child’s vaccination provider(s) to collect the information on the types of vaccinations, number of doses, dates of administration, and other administrative data about the health care facility. Estimates of vaccination coverage are determined for child and teen vaccinations recommended by the Advisory Committee on Immunization Practices (ACIP), and children and teens are classified as being up to date based on the ACIP-recommended numbers of doses for each vaccine.
The NIS-Adult COVID Module (NIS-ACM) was added in April 2021 in response to the COVID-19 pandemic,  to assess COVID-19 vaccination coverage in adults 18 years and older.
The NIS-Child COVID Module (NIS-CCM) was added in July 2021 in response to the COVID-19 pandemic, to assess COVID-19 vaccination coverage among children and teens in eligible age groups for the COVID-19 vaccine.
Surveys Conducted by NORC
The NIS are run by NORC at the University of Chicago (http://www.norc.org/) under the direction of CDC. If you have any questions about the NIS, please call NORC toll-free at 1-877-220-4805 and leave a detailed message.
If you prefer to use a TTY, please call the AT&T Relay Service toll-free at 1-800-855-2880 and request that NORC be called at 1-877-220-4805.
Current Surveys
CDC is currently conducting five surveys to assess vaccination coverage in children and adolescents:
National Immunization Survey-Child (NIS-Child) [91 pages] for children between 19 and 35 months;
National Immunization Survey-Teen (NIS-Teen) [101 pages] for adolescents 13-17 years;
National Immunization Survey-Child Influenza Module (NIS-CIM) [35 pages] for children 6-18 months and 3-12 years who were not included in the NIS-Child or NIS-Teen; and
National Immunization Survey-Adult COVID Module (NIS-ACM) [28 pages] for adults 18 years of age and older.National Immunization Survey-Child (NIS-Child)
Purpose and Scope
The NIS-Child was the first of the NIS, launched in 1994. The target population for the NIS-Child is children who are or will be 19-35 months within a few weeks of being selected to participate in the survey and living in the United States. Data are used to monitor vaccination coverage among 2-year-old children at the national, state, selected local levels, and some in U.S. territories.
The NIS-Child measures coverage of the following recommended vaccinations:
Diphtheria and tetanus toxoids and acellular pertussis vaccine (DTaP/DT/DTP)
Poliovirus vaccine (Polio)
Measles or Measles-Mumps-Rubella vaccine (MMR)
*Haemophilus influenzae* type b vaccine (Hib)
Hepatitis B vaccine (HepB)
Varicella zoster (chickenpox) vaccine (VAR)
Pneumococcal conjugate vaccine (PCV)
Rotavirus vaccine (ROT)
Hepatitis A vaccine (HepA)
Influenza vaccine (Flu)NIS-Child collects data in two parts:
A household telephone survey [91 pages]. This survey is answered by parents and guardians, includes questions about vaccinations for their children 19-35 months, and asks permission to contact vaccination providers. (See Frequently Asked Questions about the Surveys for Participants.)
A mail survey of vaccination providers called the Immunization History Questionnaire [4 pages], (Spanish version [4 pages]). This survey is sent to doctors and other vaccination providers when a parent or guardian gives permission to collect data from vaccination providers. The Immunization History Questionnaire includes a reporting form for the types of vaccinations received, the number of doses, and the dates of administration. Questions are also asked about the practice, including the type of health care facility. (See Frequently Asked Questions about the Surveys for Vaccination Providers.)For additional information on results from the NIS-Child, see ChildVaxView.
National Immunization Survey-Teen (NIS-Teen)
Purpose and Scope
The NIS-Teen was launched in 2006. The target population for the NIS-Teen is adolescents 13–17 years living in the United States at the time of the interview. Data are used to monitor vaccination coverage among teens at the national, state, and selected local levels, and some in U.S. territories.
The NIS-Teen includes coverage of the following routine adolescent vaccines:
Tetanus, diphtheria, acellular pertussis (Tdap)
Meningococcal conjugate (MenACWY)
Human papillomavirus (HPV)
Influenza vaccine (Flu)NIS-Teen collects information in two parts:
A household telephone survey [101 pages]. This survey is answered by parents and guardians and includes questions about vaccinations for their teen 13–17 years and asks permission to contact vaccination providers. (See Frequently Asked Questions about the Surveys for Participants.)
A mail survey of vaccination providers called the Immunization History Questionnaire [4 pages], (Spanish version [4 pages]). This survey is sent to doctors and other vaccination providers when a parent or guardian gives permission to collect data from vaccination providers. The Immunization History Questionnaire includes a reporting form for the types of vaccinations received, the number of doses, and their dates of administration. Questions are also asked about the practice, including the type of health care facility. (See Frequently Asked Questions about the Surveys for Vaccination Providers.)For additional information on results from the NIS-Teen, see TeenVaxView.
National Immunization Survey-Child Influenza Module (NIS-CIM)
Purpose and Scope
A short flu vaccination questionnaire, the National Immunization Survey-Child Influenza Module [35 pages] (NIS-CIM), is conducted from October through June each year for children 6–18 months and 3–12 years. Parents and guardians are asked if their children had a flu vaccination and, if so, in which month and year. If the child received a vaccination, respondents are asked how many vaccine doses the child received and whether it was a flu shot or a flu nasal spray. Additional questions about flu vaccination are also asked.
National Immunization Survey-Flu (NIS-Flu)
The flu vaccination questions in the NIS-CIM are also included in the NIS and NIS-Teen. The NIS-Flu combines the flu vaccination responses collected from NIS (children 19–35 months), NIS-Teen (adolescents 13–17 years), and NIS-CIM (children 6–18 months and 3–12 years).  NIS-Flu data are used to assess annual flu vaccination coverage among children 6 months–17 years at the national level, state level, and selected local levels, and some in U.S. territories.  These NIS-Flu estimates are based on the parent or guardian-reported data.
For additional information and seasonal flu estimates, please visit FluVaxView.
National Immunization Survey-Child COVID Module (NIS-CCM)
Purpose and Scope
The National Immunization Survey-Child COVID Module [35 pages] (NIS-CCM) was added in July 2021 and was answered by parents and guardians to assess COVID-19 vaccination coverage among children and teens in eligible age groups. Data collection for the NIS-CCM was discontinued on December 31, 2023. Selected questions about COVID vaccination and intent were added to the NIS-CIM, beginning January 2, 2024.
National Immunization Survey-Adult COVID Module (NIS-ACM)
Purpose and Scope
The National Immunization Survey-Adult COVID Module [28 pages] (NIS-ACM), will be conducted from April – December 2021 among adults 18 years and older. The survey will be used to monitor COVID-19 vaccination uptake and confidence in vaccination among adults.Top of Page
							
					
							Last Reviewed:  January 23, 2018						Source: 	National Center for Immunization and Respiratory Diseases, Immunization Services Division
					Facebook
        Twitter
        LinkedIn
        Syndicate NIS Home
About NIS
For Participants
Frequently Asked Questions
For Health Care Professionals
Frequently Asked Questions
Data, Tables, and Documentation
NIS-Child Data and Documentation for 2015 to Present
NIS-Teen Data and Documentation for 2015 to Present
Methods
Publications and Resources
Confidentiality


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue